Ferozsons Laboratories Limited.

Ferozsons Laboratories Limited, established in 1954 and listed on the Pakistan Stock Exchange (PSE), is a pioneering pharmaceutical leader with a legacy of 70+ years in delivering innovative healthcare solutions. We specialize in therapeutic leadership across:

✔ Gastroenterology & Hepatology – Digestive and liver health
✔ Cardiology & Oncology – Chronic and critical care treatments
✔ Endocrinology – Diabetes and metabolic disorders
✔ Mother & Child Health – Prenatal and pediatric formulations

Strategic International Partnerships:

Bagó Group (Argentina) – Specialty pharmaceuticals

BioGaia (Sweden) – Probiotics and gut health

Biofreeze (Performance Health, USA) – Pain relief therapies

Why Ferozsons?
✅ Therapeutic Excellence – Market-leading brands in niche segments
✅ Global Collaborations – Cutting-edge technology transfers
✅ GMP-Compliant Manufacturing – WHO, EU, and local DRAP standards
✅ Publicly Listed Transparency – PSE-listed with investor confidence

How HEMS EXPORTERS Will Strengthen Ferozsons’ Global Expansion
1️⃣ Specialty Therapy Dominance

Oncology & Cardiology – Target EU/US biosimilar pathways

Women’s Health – Partner with UNFPA for emerging markets

2️⃣ Partnership Leveraging

Co-branding with BioGaia for probiotic expansion in MENA

Biofreeze OEM production for Asian physiotherapy markets